Cefixime is used to treat bacterial infections in many different parts of the body. It belongs to the class of medicines ...

County health officials have identified what appears to be a strain unique to Los Angeles amid a spike in drug-resistant ...

The Johnson & Johnson drug Darzalex showed promise in helping keep a precancerous condition from progressing to the blood ...

FDC informed that the drug maker has received final approval from United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Cefixime 400 mg tablets.

Conclusion. Ceftobiprole is a novel, broad-spectrum, parenteral cephalosporin undergoing Phase III clinical trials. Its broad spectrum of activity makes it a candidate for monotherapy of cSSSIs ...

Novartis exited novel antibiotics R&D three years ago, but is clearly still interested in the category – its Sandoz unit has just spent $350 million buying GlaxoSmithKline’s cephalosporin ...

Future Microbiol. 2012;7(12):1401-1422. † Genetic resistance determinants (penA, mtrR and penB) elucidated. MLST: Multilocus sequence typing; ND: Not determined; NG ...

Research shows the presence of cloudy effluent in peritoneal dialysis-associated peritonitis is highly predictive of ...

Dec. 19, 2024 — Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, named VU319, is the first end ...

Basilea enters agreement with Innoviva Specialty Therapeutics for commercialization of antibiotic Zevtera in US: Allschwil, Switzerland Tuesday, December 17, 2024, 15:00 Hrs [IST] ...